Oral Therapy Usage Preferences Survey

As you know, the Sarcoma Foundation of America (SFA) partners with sarcoma researchers and industry to find more and better therapies for sarcoma patients. To that end, SFA is interested in learning about patient preferences for the usage of oral therapies. You do not have to currently take/or have taken an oral therapy in the past to participate in this short survey.

No identifiable personal or contact information will be shared, but survey responses will be aggregated and shared with external partners in an effort to include patient feedback in the therapy development process.

1.I am a...

Sarcoma Patient in Active Treatment

Sarcoma Survivor

Caregiver

2.If you selected Sarcoma Patient in Active Treatment or Sarcoma Survivor, please provide your disease subtype. If you are not a patient or survivor, please enter "N/A."

3.Have you ever taken an oral therapy as a part of your treatment? An oral therapy is any drug in tablet, capsule, or liquid form taken by mouth.

Yes

4.Using a scale of 1 (not at all challenging) to 5 (very challenging), how challenging do you think it would be to maintain a prescribed oral therapy daily which requires following therapy timing and dietary restrictions?

For example, a prescribed oral therapy requires 1) a daily dose of twice per day, 2) the patient to fast one hour before food OR two hours after food, and 3) the patient to maintain a strict low fat diet.

5.If the effectiveness of the treatment did not change, but there was an option to take a lower dose of the therapy and not have to follow the dietary and timing restrictions, would you prefer to take a lower dose of the therapy?

Yes

No preference

Comments

6.On a scale of 1 (not at all difficult) to 5 (very difficult), how difficult would you find it to accurately determine what foods are allowed under the dietary restrictions and to maintain a low fat diet?

7.What are the barriers you have faced when taking an oral therapy?

If you are not a patient or survivor, please enter "N/A.

8.Any other comments or feedback about taking an oral therapy?

9.Are you interested in participating in future research advocacy initiatives, surveys, patient focus groups, or other research projects?

Yes

If yes, please provide the email address where you can be contacted with future opportunities. This email address will not be shared with anyone outside of the Sarcoma Foundation of America.